
This year marks a significant moment for Medimaps at RSNA 2026: its first show since its merger with Radiobotics earlier this year. “Two teams, one stand and a shared vision of an era where healthy bones are the norm,” the company says.
That vision starts with a problem radiology sees every day. According to the International Osteoporosis Foundation, one in three women and one in five men over 50 will have a fragility fracture, and a first fracture approximately doubles the risk of another.
“Osteoporosis is silent until it isn’t, and many of the patients most at risk pass through imaging departments without a bone health conversation ever starting,” the company points out.
Medimaps brings together two complementary areas of expertise. The company is the creator of TBS (Trabecular Bone Score), which it says is the global standard in bone microarchitecture assessment, supported by more than 1,600 publications and cited in clinical guidelines worldwide. Radiobotics brings deep experience in AI for MSK x-ray. Together, they are focused on the moments in the imaging pathway where bone health is decided and on helping radiology teams act on them.
On the stand, the team will be talking about where bone health fits in the future of radiology, from fracture risk assessment on DXA to the role imaging AI can play across the MSK care continuum.
Visit Medimaps at RSNA 2026 on booth 2758 AI showcase – South Hall.
Visit our dedicated RSNA conference page to find out more.


